#199 Prostate Cancer Genetics with Heather Cheng
DNA Today: A Genetics Podcast
What's the Current Treatment for Prostate Cancer?
Perken elmer offers prenatal whole genom sequencing as well as ultra rapid hold genom sequencing for critically ill newborns using dried blood spots. The ultra rapid genome has turnaround time of five days and includes mito chromosomoand v analysis, s t r t n r screening and bio chemical analysis. Also listen back to episode one, 76 with doctor maduri hegda, where we explore the power of whold genum sequencing.
We have two special announcements!
Next episode we will be celebrating a decade of DNA Today! That’s right, we released our first episode on September 1st, 2012. It also coincides with our 200th episode. We want to mark these milestones with you on the show. So send in your favorite episode. You can write it, or better yet, record a voice memo sharing your favorite episode and why you enjoy listening to the show. After all, our podcast would not be possible without you loyal listeners. That’s why we want to celebrate together! Send in your voice memo or written message about your fav episode of DNA Today to info@dnapodcast.com. Deadline is August 27th.
Thank you to all you listeners for nominating us in the Podcast Awards, you did it! We have officially been nominated. It’s year number 6 being nominated and it might be our third time winning the Best Science and Medicine Podcast Award. BUT that’s only going to happen if you check your email inbox for an email from The Podcast Awards with the subject line, “Podcast Awards Final Slate Voting”'. If you got this email you are one of the few that were selected to be a voter. It’s imperative that you vote! There is a hyperlink to click to get to the voting page. You do have to quickly log back in. Once you do, select DNA Today in the “Science and Medicine category”, select your other fav podcasts and then Hit the “Save Nominations” button. It’s that easy. You have until September 10th to do this, but please do it now if you got the email so you don’t forget!
In this episode we are educating you about prostate cancer as we are on the cusp of prostate cancer awareness month starting next week. Joining us for this discussion is Dr. Heather Cheng, Director of the Prostate Cancer Genetics Clinic at the Seattle Cancer Care Alliance, Assistant Professor in the Division of Medical Oncology at the University of Washington School of Medicine, and Associate Professor in the Clinical Research Division at the Fred Hutchinson Cancer Research Center. She focuses on improving the care of patients with prostate and bladder cancers. An expert in prostate cancer genetics, she is studying ways to use genetics to guide the care of prostate cancer patients and their family members who may also be at high risk for the disease.
On This Episode We Discuss:
The prevalence of prostate cancer
Signs of hereditary prostate cancer in family history
Prostate Cancer Registry of Outcomes and Germline Mutations (PROMISE)
The goals of PROMISE
Who is eligible to enroll in PROMISE and what is required
The most common genes that are identified as having a pathogenic variant
Current treatments available for people with prostate cancer
The lifetime risk of prostate cancer
To learn more about the PROMISE study, visit the study website and check out this
You can keep up with our guest, Heather Cheng on Twitter, and LinkedIn, and stay up to date with the latest developments in prostate cancer research by following the Prostate Cancer Foundation on Twitter and LinkedIn, and Instagram.
Next episode of DNA Today on September 2nd, 2022, we are celebrating 200 episodes and 10 years of the show! New episodes are released on Fridays. In the meantime, you can binge all our other episodes on Apple Podcasts, Spotify, streaming on the website, or any other podcast player by searching, “DNA Today”. Episodes since 2021 are also recorded with video which you can watch on our YouTube channel.
DNA Today is hosted and produced by Kira Dineen. Our social media lead is Corinne Merlino. Our video lead is Amanda Andreoli.
See what else we are up to on Twitter, Instagram, Facebook, YouTube and our website, DNApodcast.com. Questions/inquiries can be sent to info@DNApodcast.com.
PerkinElmer Genomics is a global leader in genetic testing focusing on rare diseases, inherited disorders, newborn screening, and hereditary cancer. Testing services support the full continuum of care from preconception and prenatal to neonatal, pediatric, and adult. Testing options include sequencing for targeted genes, multiple genes, the whole exome or genome, and copy number variations. Using a simple saliva or blood sample, PerkinElmer Genomics answers complex genetic questions that can proactively inform patient care and end the diagnostic odyssey for families. Learn more at PerkinElmerGenomics.com. (SPONSORED)
The AI-powered Podcast Player
